On 12 Nov 2026 Lam Research closed at $233.78, +37.0% this year; market cap $293.57bn, P/E 34.7.
Information Technology · Semiconductor Materials & Equipment · NASDAQ · United States
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company offers ALTUS systems to deposit conformal or selective films for tungsten or molybdenum metallization applications; SABRE electrochemical deposition products for copper interconnect transition, which support copper damascene manufacturing; Striker single-wafer atomic layer deposition products for dielectric film solutions; and VECTOR plasma-enhanced chemical vapor deposition (CVD) products. It also provides Akara, a conductor etch system designed to enhance etch precision, selectivity, and defect control; Argos, Prevos, and Selis, which are selective etch systems used in the fabrication of advanced logic and memory devices that require precise control at nanoscale dimensions; Flex for dielectric etch applications; Vantex, a dielectric etch system that provides RF technology and repeatable wafer-to-wafer performance enabled by Equipment Intelligence solutions; Kiyo for conductor etch applications; Syndion for deep silicon etch; and Versys metal products for metal etch processes. In addition, the company offers Coronus bevel clean products to enhance die yield and Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications. Further, it provides Reliant deposition, etch, and clean products; Sense.i platform products; and customer service, spares, and upgrades. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
| Market cap | $293.57bn |
| P/E (trailing) | 34.7 |
| EPS (TTM) | $6.73 |
| Beta | 2.01 |
| Dividend | $1.32 |
| Dividend yield | 0.56% |
| Ex-dividend date | 2 Dec 2026 |
| Latest report | 21 Oct 2026 |
| Next earnings | 13 Jan 2027 |
| YTD | +37.0% |
| 1Y | +45.5% |
| 3Y | +52.7% |
| 5Y | +31.6% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $23.23bn | $7.27bn | $4.89bn |
| 2025 | $18.44bn | $5.36bn | $5.41bn |
| 2024 | $14.91bn | $3.83bn | $4.26bn |
| 2023 | $17.43bn | $4.51bn | $4.68bn |
| 2022 | $17.23bn | $4.61bn | $2.55bn |
We publish no single base value for Lam Research. Our valuation methods put it between $297.25 and $321.53 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.